Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Heme A synthesis and CcO activity are essential for Trypanosoma cruzi infectivity and replication.

Merli ML, Cirulli BA, Menéndez-Bravo SM, Cricco JA.

Biochem J. 2017 Jun 27;474(14):2315-2332. doi: 10.1042/BCJ20170084.

PMID:
28588043
2.

The Trypanosoma cruzi Protein TcHTE Is Critical for Heme Uptake.

Merli ML, Pagura L, Hernández J, Barisón MJ, Pral EM, Silber AM, Cricco JA.

PLoS Negl Trop Dis. 2016 Jan 11;10(1):e0004359. doi: 10.1371/journal.pntd.0004359. eCollection 2016 Jan.

3.

Platelet-Rich Plasma Intra-articular Knee Injections Show No Superiority Versus Viscosupplementation: A Randomized Controlled Trial.

Filardo G, Di Matteo B, Di Martino A, Merli ML, Cenacchi A, Fornasari P, Marcacci M, Kon E.

Am J Sports Med. 2015 Jul;43(7):1575-82. doi: 10.1177/0363546515582027. Epub 2015 May 7.

PMID:
25952818
4.

Platelet-rich plasma: why intra-articular? A systematic review of preclinical studies and clinical evidence on PRP for joint degeneration.

Filardo G, Kon E, Roffi A, Di Matteo B, Merli ML, Marcacci M.

Knee Surg Sports Traumatol Arthrosc. 2015 Sep;23(9):2459-74. doi: 10.1007/s00167-013-2743-1. Epub 2013 Nov 26. Review.

5.

Leukocyte-poor PRP application for the treatment of knee osteoarthritis.

Filardo G, Kon E, DI Matteo B, DI Marino A, Sessa A, Merli ML, Marcacci M.

Joints. 2014 Jan 8;1(3):112-20. eCollection 2013 Jul-Sep.

6.

Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: study design and preliminary results of a randomized controlled trial.

Filardo G, Kon E, Di Martino A, Di Matteo B, Merli ML, Cenacchi A, Fornasari PM, Marcacci M.

BMC Musculoskelet Disord. 2012 Nov 23;13:229. doi: 10.1186/1471-2474-13-229.

7.

Bone regeneration with mesenchymal stem cells.

Kon E, Filardo G, Roffi A, Di Martino A, Hamdan M, De Pasqual L, Merli ML, Marcacci M.

Clin Cases Miner Bone Metab. 2012 Jan;9(1):24-7. Epub 2012 May 29.

Supplemental Content

Loading ...
Support Center